Feldpausch D L, Needham L M, Stone M P, Althaus J S, Yamamoto B K, Svensson K A, Merchant K M
Central Nervous System Diseases Research, Pharmacia & Upjohn, Inc., Kalamazoo, Michigan, USA.
J Pharmacol Exp Ther. 1998 Jul;286(1):497-508.
Our studies examined the role of dopamine D4 receptors in the induction of behavioral sensitization to amphetamine (Amp) and accompanying neurochemical and molecular adaptive responses using a highly selective D4 antagonist, PNU-101387G. Behavioral sensitization to an acute challenge of Amp (2 mg/kg, s.c.) was observed in rats pretreated with five daily doses of Amp (2 mg/kg/d, s.c.) followed by 7-day withdrawal. Interestingly, coadministration of PNU-101387G with Amp during pretreatment completely blocked the sensitized response to an acute Amp challenge. The behavioral sensitization and its blockade by the D4 antagonist were observed in the absence of significant differences in cerebellar Amp levels among the various pretreatment groups. Accompanying behavioral sensitization were two postsynaptic neuroadaptive responses: reduction in the ability of Amp to induce c-fos gene expression in the infralimbic/ventral prelimbic cortex and NT/N mRNA in the accumbal shell. However, concurrent blockade of D4 receptors during Amp pretreatment prevented the refractoriness in c-fos and NT/N responsiveness to acute Amp. We observed also a presynaptic neuroplastic response associated with the behavioral sensitization: a significant augmentation in the ability of Amp to increase extracellular dopamine concentrations in the nucleus accumbens shell. As with the behavioral sensitization and associated postsynaptic adaptive responses, concurrent administration of PNU-101387G with Amp during pretreatment blocked the augmentation in Amp-induced dopamine release. Taken together, these data demonstrate that dopamine D4 receptors play an important role in the induction of behavioral sensitization to Amp and accompanying adaptations in pre- and postsynaptic neural systems associated with the mesolimbocortical dopamine projections.
我们的研究使用一种高度选择性的D4拮抗剂PNU-101387G,研究了多巴胺D4受体在对苯丙胺(Amp)产生行为敏化以及伴随的神经化学和分子适应性反应诱导过程中的作用。在用五剂Amp(2mg/kg/天,皮下注射)预处理大鼠,随后停药7天后,观察到对急性Amp刺激(2mg/kg,皮下注射)产生行为敏化。有趣的是,在预处理期间将PNU-101387G与Amp共同给药完全阻断了对急性Amp刺激的敏化反应。在各预处理组间小脑Amp水平无显著差异的情况下,观察到行为敏化及其被D4拮抗剂阻断的现象。伴随行为敏化出现了两种突触后神经适应性反应:Amp诱导下边缘/腹侧前边缘皮质中c-fos基因表达以及伏隔核壳中NT/N mRNA表达的能力降低。然而,在Amp预处理期间同时阻断D4受体可防止c-fos和NT/N对急性Amp反应性的不应性。我们还观察到一种与行为敏化相关的突触前神经可塑性反应:Amp增加伏隔核壳细胞外多巴胺浓度的能力显著增强。与行为敏化及相关的突触后适应性反应一样,在预处理期间将PNU-101387G与Amp同时给药可阻断Amp诱导的多巴胺释放增加。综上所述,这些数据表明多巴胺D4受体在对Amp产生行为敏化以及与中脑边缘皮质多巴胺投射相关的突触前和突触后神经系统的伴随适应性反应的诱导过程中起重要作用。